First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component-Reference-Cited by-同舟云学术

First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component

Published:2021-05 Issue:10 Volume:10 Page:3388-3402
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Zhou Yu‐Wen¹,Long Yi‐Xiu¹,Chen Ye²,Liu Ji‐Yan¹^ORCID,Pu Dan³,Huang Jia‐Yan⁴,Bi Feng²,Li Qiu²^ORCID,Gou Hong‐Feng²^ORCID,Qiu Meng²^ORCID

Affiliation:

1. Department of Biotherapy Cancer CenterWest China Hospital of Sichuan University Chengdu China

2. Department of Abdominal Oncology Cancer CenterWest China Hospital of Sichuan University Chengdu China

3. Lung Cancer Center West China HospitalSichuan University Chengdu China

4. Department of Radiology and Medical Ultrasound West China Hospital of Sichuan University Chengdu China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3876

Reference50 articles.

1. Mucinous Rectal Cancer: Effectiveness of Preoperative Chemoradiotherapy and Prognosis

2. Prognostic Comparison Between Mucinous and Nonmucinous Adenocarcinoma in Colorectal Cancer

3. Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data Base

4. Advances in the care of patients with mucinous colorectal cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of bevacizumab on clinical outcomes and its comparison with standard chemotherapy in metastatic colorectal cancer patients: a systematic review and meta-analysis;Journal of Pharmaceutical Policy and Practice;2024-06-05

2. Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma;Cancer Research Communications;2024-05-29

3. Conditional survival nomogram for patients with colon mucinous adenocarcinoma to predict prognosis: a dynamic survival analysis;Updates in Surgery;2024-05-10

4. Favorable treatment response of bevacizumab-combined chemotherapy for advanced or recurrent invasive mucinous adenocarcinoma of the lung: A retrospective observational study;Respiratory Investigation;2024-05

5. Acute inflammatory reaction during anti-angiogenesis therapy combined with immunotherapy as a possible indicator of the therapeutic effect: Three case reports and literature review;Frontiers in Oncology;2023-04-14